These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17103226)

  • 1. Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas.
    Shintani K; Matsumine A; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Hoki Y; Uchida A
    Virchows Arch; 2006 Dec; 449(6):673-81. PubMed ID: 17103226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
    Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
    Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
    Pansare V; Munkarah AR; Schimp V; Haitham Arabi M; Saed GM; Morris RT; Ali-Fehmi R
    Mod Pathol; 2007 Jan; 20(1):35-43. PubMed ID: 17099695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
    Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
    Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced factor-1 alpha, vascular endothelial growth factor expression in BRCA1-related breast cancer: A prospective study in tertiary care hospital.
    Sharma M; Piplani S; Madan M; Manjari M; Garg S; Kaur K
    Indian J Pathol Microbiol; 2017; 60(4):469-474. PubMed ID: 29323057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
    Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
    Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.
    Fukushima S; Endo M; Matsumoto Y; Fukushi JI; Matsunobu T; Kawaguchi KI; Setsu N; IIda K; Yokoyama N; Nakagawa M; Yahiro K; Oda Y; Iwamoto Y; Nakashima Y
    PLoS One; 2017; 12(5):e0178064. PubMed ID: 28558056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
    Badowska-Kozakiewicz A; Sobol M; Patera J
    Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
    Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
    Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
    BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
    Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival.
    Ji X; Wang H; Zhu J; Tang Y; Zhou Y; Zhu L; Gao C; Li W; You W; Yu B; Xia Q
    Neurol Res; 2013 Dec; 35(10):1044-50. PubMed ID: 24070025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.